A Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) Enzyme Replacement Therapy in Gaucher Disease

Clinical trial NCT00430625 · COMPLETED

Trial details

NCT number: NCT00430625
Sponsor: Shire
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Gaucher Disease, Type 1

Start date: 2007-02-15
Primary completion: 2009-04-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.